Stifel Financial Corp Ptc Therapeutics, Inc. Transaction History

Stifel Financial Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$41.85 - $53.85 $173,761 - $223,585	4,152 New	4,152 $208,000
Q4 2021 Feb 14, 2022	SELL	$35.36 - $41.86 $204,168 - $241,699	-5,774 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$37.01 - $44.74 $213,695 - $258,328	5,774 New	5,774 $215,000
Q1 2021 May 14, 2021	SELL	$46.8 - $68.92 $169,930 - $250,248	-3,631 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$47.96 - $67.64 $174,142 - $245,600	3,631 New	3,631 $222,000
Q3 2020 Nov 16, 2020	SELL	$45.41 - $57.07 $182,094 - $228,850	-4,010 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$42.56 - $54.98 $170,665 - $220,469	4,010 New	4,010 $203,000
Q1 2020 May 14, 2020	SELL	$32.37 - $59.36 $210,437 - $385,899	-6,501 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$32.22 - $50.07 $209,462 - $325,505	6,501 New	6,501 $312,000

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.31B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.